Hyo Jin Kang
Inventor
Stats
- 2 US patents issued
- 11 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 2 US Patents Issued
- 11 US Applications Filed
- 21 Total Citation Count
- May 9, 2022 Most Recent Filing
- Dec 8, 2005 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY | 2
2 2 | 2007
2008 2012 |
BIONEER CORPORATION | 1
| 2005
|
GEORGETOWN UNIVERSITY | 1
| 2014
|
Inventor Addresses
Address | Duration |
---|---|
Cheonan-si, KR | May 07, 20 - Nov 09, 21 |
Daejeon, KR | Jun 18, 09 - Aug 28, 14 |
Fairfax, VA, US | Jun 16, 16 - Nov 19, 19 |
Gyeonggi-do, KR | Oct 12, 23 - Oct 12, 23 |
Pohang-si, KR | Aug 05, 10 - Feb 04, 14 |
Seoul, KR | May 09, 19 - Mar 03, 20 |
Suwon-si, KR | Mar 06, 25 - Mar 06, 25 |
Vancouver, CA | Mar 24, 22 - Mar 24, 22 |
Technology Profile
Technology | Matters | |
---|---|---|
A61B: | DIAGNOSIS; SURGERY; IDENTIFICATION | 1 |
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 3 |
A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 1 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
2025/0075,003 | 2025 | NANOPARTICLES COMPRISING FUSION PROTEIN OF SINGLE-CHAIN VARIABLE FRAGMENT AND FERRITIN, AND USE THEREOF | 0 |
2023/0322,723 | 2023 | COMPOUNDS FOR SUPPRESSING EGFR MUTANT CANCER AND PHARMACEUTICAL USE THEREOF | 0 |
2022/0087,548 | 2022 | SYSTEMS AND METHODS FOR DETERMINING TIMING FOR FLUORESCENCE BASED BLOOD FLOW ASSESSMENT | 0 |
11171473 | 2021 | Support module for transmission line sleeve | 0 |
2020/0144,805 | 2020 | SUPPORT MODULE FOR TRANSMISSION LINE SLEEVE | 5 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.